|
UA76934C2
(en)
|
1996-10-04 |
2006-10-16 |
Chugai Pharmaceutical Co Ltd |
Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
|
|
US6986890B1
(en)
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
|
US6428965B1
(en)
|
1997-07-17 |
2002-08-06 |
The Johns Hopkins University |
Screening assays for the interaction of semaphorins and neuropilins
|
|
CA2313390A1
(en)
|
1997-12-09 |
1999-06-17 |
Children's Medical Center Corporation |
Peptide antagonists of vascular endothelial growth factor
|
|
EP1037981A1
(en)
|
1997-12-09 |
2000-09-27 |
Children's Medical Center Corporation |
Soluble inhibitors of vascular endothelial growth factor and use thereof
|
|
CA2313607A1
(en)
|
1997-12-09 |
1999-06-17 |
Children's Medical Center Corporation |
Antagonists of neuropilin receptor function and use thereof
|
|
WO2000029447A1
(en)
|
1998-11-19 |
2000-05-25 |
Smithkline Beecham Corporation |
Rhamm antagonist antibodies
|
|
US20040038339A1
(en)
*
|
2000-03-24 |
2004-02-26 |
Peter Kufer |
Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
|
|
US7183388B2
(en)
|
2001-03-30 |
2007-02-27 |
The Regents Of The University Of California |
Anti-MUC-1 single chain antibodies for tumor targeting
|
|
US20040214766A1
(en)
|
2001-10-01 |
2004-10-28 |
Kari Alitalo |
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
|
US20030113324A1
(en)
|
2001-10-01 |
2003-06-19 |
Kari Alitalo |
Neuropilin/VEGF-C/VEGFR-3 materials and methods
|
|
ATE525398T1
(de)
|
2002-05-10 |
2011-10-15 |
Medimmune Inc |
Epha2 monoklonale antikörper und deren anwendungsverfahren
|
|
UA89348C2
(ru)
|
2002-10-16 |
2010-01-25 |
Евро-Селтик С.А. |
Изолированное моноклональное антитело, которое связывает клеточно-ассоциированный полипептид са 125/о772р
|
|
WO2004035537A2
(en)
|
2002-10-16 |
2004-04-29 |
Euro-Celtique S.A. |
Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US7982011B2
(en)
*
|
2003-11-25 |
2011-07-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutated anti-cd22 antibodies and immunoconjugates
|
|
CN101426489A
(zh)
|
2004-04-16 |
2009-05-06 |
曹义海 |
抑制血管生成的成分和方法
|
|
US20090196850A1
(en)
|
2005-01-06 |
2009-08-06 |
Novo Nordisk A/S |
Anti-Kir Combination Treatments and Methods
|
|
EP1739092A1
(en)
|
2005-06-28 |
2007-01-03 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Peptidic antagonists of class III semaphorins/neuropilins complexes
|
|
WO2007011896A2
(en)
|
2005-07-18 |
2007-01-25 |
The Trustees Of Boston University |
Method to inhibit proliferation and growth of metastases
|
|
WO2007020075A1
(en)
|
2005-08-16 |
2007-02-22 |
Klinikum Der Universität Regensburg |
Use of neuropilin-2 antagonists
|
|
UA96139C2
(uk)
*
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
US7420040B2
(en)
|
2006-02-24 |
2008-09-02 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
EP2162552A4
(en)
|
2007-05-11 |
2010-06-30 |
Univ Johns Hopkins |
BIOMARKER FOR MELANOME
|
|
JP5745840B2
(ja)
*
|
2007-05-17 |
2015-07-08 |
ジェネンテック， インコーポレイテッド |
抗ニューロピリン２抗体による腫瘍転移の阻害
|
|
KR101523788B1
(ko)
|
2007-05-17 |
2015-06-26 |
제넨테크, 인크. |
뉴로필린 단편 및 뉴로필린-항체 복합체의 결정 구조
|
|
AR068723A1
(es)
|
2007-10-05 |
2009-12-02 |
Glaxo Group Ltd |
Proteina que se une a antigenos que se une a il-23 humana y sus usos
|
|
BRPI0909541A2
(pt)
|
2008-05-27 |
2016-10-11 |
Pluristem Ltd |
''método para tratamento de doenças inflamatórias do cólon''
|
|
FR2935385B1
(fr)
|
2008-08-27 |
2013-04-19 |
Diaclone |
Induction de l'expression de p53 par neutralisation de la neuropiline-2 pour le traitement des cancers
|
|
CN102308212A
(zh)
|
2008-12-04 |
2012-01-04 |
加利福尼亚大学董事会 |
用于确定前列腺癌诊断和预后的材料和方法
|
|
PT2374883T
(pt)
*
|
2008-12-26 |
2016-10-20 |
Kyowa Hakko Kirin Co Ltd |
Anticorpo anti-cd4
|
|
TWI541021B
(zh)
|
2009-03-05 |
2016-07-11 |
艾伯維有限公司 |
Ｉｌ－１７結合蛋白
|
|
AU2010226726B8
(en)
|
2009-03-16 |
2014-08-14 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
RU2012114094A
(ru)
|
2009-09-11 |
2013-10-20 |
Дженентек, Инк. |
Способ идентификации пациента с увеличенной вероятностью ответа на противораковый агент
|
|
KR20120089863A
(ko)
|
2009-10-09 |
2012-08-14 |
사노피 |
“개선된 당화반응 최종 생성물에 대한 수용체”에 결합하기 위한 폴리펩타이드 및 이를 포함하는 조성물 및 방법
|
|
EP2488874A4
(en)
|
2009-10-13 |
2013-08-14 |
Univ Johns Hopkins |
BIOMARKERS FOR THE IDENTIFICATION OF MELANOMOTUM CELLS
|
|
TWI667257B
(zh)
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的ＦｃＲｎ親和力之抗體
|
|
HUE049849T2
(hu)
|
2010-03-31 |
2020-10-28 |
Boehringer Ingelheim Int |
Anti-CD40 antitestek
|
|
US9243057B2
(en)
|
2010-08-31 |
2016-01-26 |
The Regents Of The University Of California |
Antibodies for botulinum neurotoxins
|
|
AU2011333738A1
(en)
|
2010-11-24 |
2013-07-11 |
Glaxo Group Limited |
Multispecific antigen binding proteins targeting HGF
|
|
WO2012144208A1
(ja)
|
2011-04-18 |
2012-10-26 |
国立大学法人東京大学 |
抗itm2a抗体を用いる癌の診断および治療
|
|
WO2013106765A1
(en)
|
2012-01-13 |
2013-07-18 |
Genentech, Inc. |
Biological markers for identifying patients for treatment with vegf antagonists
|
|
DK2807188T3
(da)
|
2012-01-27 |
2019-10-07 |
Prothena Biosciences Ltd |
Humaniserede antistoffer, der genkender alpha-synuclein
|
|
WO2013116742A1
(en)
|
2012-02-01 |
2013-08-08 |
Mayo Foundation For Medical Education And Research |
Predicting responses to androgen deprivation therapy and methods for treating prostate cancer
|
|
DK3199552T3
(da)
|
2012-11-20 |
2020-03-30 |
Sanofi Sa |
Anti-ceacam5-antistoffer og anvendelser heraf
|
|
CA2896058A1
(en)
|
2012-12-24 |
2014-07-03 |
Abbvie Inc. |
Prolactin receptor binding proteins and uses thereof
|
|
WO2014125291A1
(en)
|
2013-02-14 |
2014-08-21 |
Ucl Business Plc |
Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
JP2016515120A
(ja)
*
|
2013-03-15 |
2016-05-26 |
バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． |
抗アルファｖベータ５抗体を用いた急性腎損傷の治療及び予防
|
|
AU2014293670B2
(en)
|
2013-07-23 |
2019-08-01 |
Immunomedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
|
WO2015095686A1
(en)
|
2013-12-20 |
2015-06-25 |
Trustees Of Boston University |
Assays and methods relating to the treatment of melanoma
|
|
EA033604B1
(ru)
|
2014-01-31 |
2019-11-08 |
Boehringer Ingelheim Int |
Молекула анти-baff антитела, фармацевтическая композиция, содержащая эту молекулу, способы ее применения и кодирующий ее изолированный полинуклеотид
|
|
KR20160131082A
(ko)
|
2014-03-12 |
2016-11-15 |
프로테나 바이오사이언시즈 리미티드 |
Lg1-3에 특이적인 항-라미닌4 항체
|
|
EP3148564B1
(en)
|
2014-06-02 |
2020-01-08 |
Children's Medical Center Corporation |
Methods and compositions for immunomodulation
|
|
MA40513A
(fr)
*
|
2014-08-12 |
2017-06-21 |
Novartis Ag |
Conjugués médicament-anticorps anti-cdh6
|
|
JP2017536102A
(ja)
|
2014-10-16 |
2017-12-07 |
ジェネンテック， インコーポレイテッド |
抗アルファ−シヌクレイン抗体及び使用方法
|
|
CR20180097A
(es)
*
|
2015-07-14 |
2018-05-25 |
Immunext Inc |
Anticuerpo anti-cd154 con caracteristicas de unión, funcionalidad y seguridad mejoradas y uso en inmunoterapia humana
|
|
EP3464349A4
(en)
|
2016-05-23 |
2020-08-26 |
New York University |
COMPOSITIONS AND METHODS ASSOCIATED WITH ANTIBODIES TARGETING STAPHYLOCCAL LEUCOTOXINS
|
|
CA3045321A1
(en)
*
|
2016-11-30 |
2018-06-07 |
Atyr Pharma, Inc. |
Anti-hrs antibodies and combination therapies for treating cancers
|
|
EP3612567B1
(en)
|
2017-04-19 |
2024-09-11 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1 antibodies and antibody drug conjugates
|
|
CA3060514A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
|
EP3694887A4
(en)
*
|
2017-10-13 |
2022-02-23 |
A & G Pharmaceutical, Inc. |
MONOCLONAL ANTIBODIES AND CONJUGATES TO PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF
|
|
KR102758204B1
(ko)
|
2017-10-30 |
2025-01-23 |
밀테니 비오텍 비.브이. & 씨오. 케이지 |
표적 세포의 선택적 형질도입을 위한 어댑터-기반 레트로바이러스 벡터 시스템
|
|
IL276286B2
(en)
|
2018-01-26 |
2025-07-01 |
Genzyme Corp |
FC variants with improved binding to FCRN and extended half-life
|
|
AU2019247511B2
(en)
|
2018-04-06 |
2025-10-16 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-NRP2 antibodies
|
|
KR20210148216A
(ko)
|
2019-04-01 |
2021-12-07 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
항-클라우딘 18.2 항체 및 이의 응용
|
|
WO2021058548A1
(en)
|
2019-09-23 |
2021-04-01 |
Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) |
Antibodies for the diagnosis and/or treatment of atherosclerosis
|
|
CA3156803A1
(en)
|
2019-10-03 |
2021-04-08 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-nrp2 antibodies
|
|
CN116075525A
(zh)
|
2020-03-31 |
2023-05-05 |
艾莱克特有限责任公司 |
抗mertk抗体及其使用方法
|
|
EP4418015A4
(en)
|
2021-10-15 |
2025-10-15 |
Shibaura Inst Tech |
IMAGE SENSOR DATA CONTROL SYSTEM
|
|
EP4423142A4
(en)
|
2021-10-27 |
2025-10-22 |
Atyr Pharma Inc |
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2A ANTIBODIES
|
|
WO2023245117A2
(en)
|
2022-06-17 |
2023-12-21 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-nrp2 antibodies
|